[account_shop_links]
Cary, N.C. – August 16, 2011 – Industry Standard Research (ISR) today announced the release of their “2011 Phase I Market Overview and Outlook” report, in which 104 pharmaceutical decision makers responsible for Phase I activities provide valuable insight into market size, growth and decline in the number of studies over the next 3 years, geographical trends in study placement, service provider selection criteria, and their experiences with service provider delivery quality.
“Of all the drug development and commercialization markets we cover, few are more dynamic and more in need of clarity than Phase I. This report is unique because it provides a quantitative look at the significant drivers of change in how Phase I studies are conducted. These include the use of patient populations, geographical shifts in the location of Phase I studies, the use of large vs. mid-size vs. dedicated Phase I service providers, and others,” explained Kevin Olson, CEO of Industry Standard Research.
Also included within ISR’s “The State of the Phase I Market” report is a section on Selection Criteria, where respondents are asked to rate the importance of 25 attributes when selecting a service provider and a section on Service Quality Rankings, where respondents are asked to rank service providers on 10 different quality dimensions.
“By coupling the market dynamics and geographical trends data with the selection criteria and quality metrics data, a service provider will have the opportunity to complete a self-assessment, determine what sponsors are looking for in their Phase I trial partners, and apply the anticipated future market trends to business development strategies” Olson explained. “And Phase I study sponsors will be able to benchmark their own conduct and outsourcing strategies against the rest of the market and use the performance data to make more informed service provider decisions.”
About Industry Standard Research
Industry Standard Research is the premier, full-service market research provider to the pharma and pharma services industries. With over a decade of experience in the industry, ISR delivers an unmatched level of domain expertise. For more information about our syndicated and custom research offerings, please visit the company’s Web site at www.ISRreports.com or email info@isrreports.com.
